General
Preferred name
URACIL
Synonyms
Uracil (BMS-205603-01 SQ-8493 SQ-7726 SQ-6201 ) ()
Uracil C-13 ()
SQ-6201 ()
SQ-8493 ()
Lamivudine impurity e ()
SQ-7726 ()
Hybar x ()
Pyrod ()
Lamivudine impurity e rs ()
Fluorouracil specified compound c ()
NSC-3970 ()
BMS-205603-01 ()
Uracil-13C,15N2 ()
Uracil-d4 ()
Uracil-13C4,15N2 ()
P&D ID
PD001670
CAS
16908-84-2
24897-50-5
138285-60-6
66-22-8
181517-11-3
24897-55-0
202407-06-5
Tags
available
drug candidate
Drug indication
Discovery agent
Antineoplastic (adjunct)
Drug Status
experimental
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
18
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugMAP
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NIH Mechanistic Set
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
62
Properties
(calculated by RDKit )
Molecular Weight
112.03
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
0
Ring Count
1
Aromatic Ring Count
1
cLogP
-0.94
TPSA
65.72
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.45
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
RNA
DPYD, UCKL1
Endogenous Metabolite
Pathway
Metabolic Enzyme/Protease
Source data
